Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists

Authors
Brooks, BR Juhasz-Poscine, K Waclawik, A Sanjak, M Belden, D Roelke, K Parnell, J Weasler, C
Citation
Br. Brooks et al., Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: Beta-2 adrenergic agonists, AMYOTROPH L, 1, 2000, pp. 45-53
Citations number
72
Categorie Soggetti
Neurology
Journal title
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS
ISSN journal
14660822 → ACNP
Volume
1
Year of publication
2000
Supplement
4
Pages
45 - 53
Database
ISI
SICI code
1466-0822(200012)1:<45:MCSFDA>2.0.ZU;2-L